financetom
Business
financetom
/
Business
/
Flutter bets on Italian gambling market with $2.6 billion Snaitech deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Flutter bets on Italian gambling market with $2.6 billion Snaitech deal
Sep 17, 2024 1:05 AM

By DhanushVignesh Babu

(Reuters) -Flutter Entertainment said on Tuesday it would buy Snaitech for 2.3 billion euros ($2.6 billion) including debt from gambling technology group Playtech, cementing its position as the leading gambling firm in Italy.

The deal is to close by the second quarter of 2025 and will add to earnings per share immediately for Flutter, the world's largest gambling company.

It will also see one of Italy's biggest gambling companies change hands and leave Playtech to focus on its operations as a business-to-business software provider.

It marks the second deal in a week for Flutter, which announced last Friday it would buy a 56% stake in Brazil's NSX Group, the operator of Betnacional, for about $350 million to expand in the soon-to-be regulated Brazilian market.

The move comes as Flutter, which has seen an influx of new customers and revenue from the United States, continues its aggressive international expansion.

Earlier this year, the company, whose brands include Paddy Power and Poker Stars, shifted its primary listing to New York from London.

The acquisition will strengthen Flutter's standing in Italy, giving it an online market share of about 30% when combined with existing Italian operations, Flutter said. Flutter already owns Sisal, one of the largest online gambling operators in Italy.

Flutter is in more than 20 countries globally, including the booming U.S. market where it operates the FanDuel brand.

Playtech has operations in 19 countries. Snaitech, its business-to-consumer unit, made 946.6 million euros in revenue last year.

The two parties have been in talks regarding Snaitech since August. Shares in the owner of FanDuel and Paddy Power added 0.8%, reaching their highest level since March 2024, while Playtech's shares rose as much as 2% to their highest since November 2021. ($1 = 0.8988 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cenovus Energy Maintained at Buy at TPH After It Agrees to Acquire MEG Energy; Price Target at C$28.00
Cenovus Energy Maintained at Buy at TPH After It Agrees to Acquire MEG Energy; Price Target at C$28.00
Aug 25, 2025
09:25 AM EDT, 08/25/2025 (MT Newswires) -- Tudor, Pickering, Holt on Monday reiterated its buy rating on the shares of Cenovus Energy ( CVE ) with a C$28.00 price target after the oil producer and refiner on Friday said it agreed to acquire oil-sands producer MEG Energy (MEG.TO) for $7.9-billion, including debt. We like the deal especially for CVE given...
White House's Hassett says US could take stakes in other chip companies
White House's Hassett says US could take stakes in other chip companies
Aug 25, 2025
WASHINGTON, Aug 25 (Reuters) - The federal government could take stakes in other U.S. semiconductor companies or even move to other industries, White House economic adviser Kevin Hassett told CNBC in an interview on Monday following its stake in Intel ( INTC ). Hassett, asked if the Intel ( INTC ) deal was the start of a larger effort by...
Bank7 Renews Stock Buyback Plan
Bank7 Renews Stock Buyback Plan
Aug 25, 2025
09:26 AM EDT, 08/25/2025 (MT Newswires) -- Bank7 ( BSVN ) said Monday the board has renewed its stock buyback plan for a two-year term. The company said the plan provides for the purchase of up to 750,000 outstanding common shares. ...
AbbVie to Buy Gilgamesh Pharmaceuticals' Bretisilocin for Up to $1.2 Billion
AbbVie to Buy Gilgamesh Pharmaceuticals' Bretisilocin for Up to $1.2 Billion
Aug 25, 2025
09:26 AM EDT, 08/25/2025 (MT Newswires) -- AbbVie ( ABBV ) has agreed to buy Gilgamesh Pharmaceuticals' lead asset bretisilocin for up to $1.2 billion, including an upfront payment and development milestones, the companies said Monday. As part of the deal, Gilgamesh will spin off an entity to be called Gilgamesh Pharma to hold its employees and other programs, including...
Copyright 2023-2026 - www.financetom.com All Rights Reserved